MP50-06 MICROPAPILLARY DIFFERENTIATION VERSUS CONVENTIONAL UROTHELIAL CARCINOMA: EFFECTS OF NEOADJUVANT CHEMOTHERAPY AND CYSTECTOMY ON SURVIVALNoah Canvasser, Jeffrey S. Montgomery, Brent K. Hollenbeck et al.|The Journal of Urology|2014Cited by 3
1766 LENGTH OF STAY FOLLOWING RADICAL CYSTECTOMY: HOW LONG IS LONG ENOUGH?Sapan N. Ambani, Todd M. Morgan, Alon Z. Weizer et al.|The Journal of Urology|2013Cited by 2
MP65-08 THE ROLE OF TRANSURETHRAL RESECTION OF BLADDER TUMOR AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCERDenise Asafu‐Adjei, Alon Z. Weizer, Cheryl Lee et al.|The Journal of Urology|2014Cited by 0
1762 HOSPITAL DISCHARGE STATUS OF ELDERLY PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR BLADDER CANCERGareth Warren, Cheryl Lee, Neil P. Shah et al.|The Journal of Urology|2013Cited by 0